The Europe digital genome market is expected to reach US$ 5,994.09 million by 2027 from US$ 3,250.04 million in 2019; it is estimated to grow at a CAGR of 8.1% from 2020 to 2027.
The key factors driving the growth of digital genomeare increasing prevalence of chronic diseases and growing funding for genomics in the region. However, security and confidentiality issue of the patient datais the major factor hindering the Europe Digital Genome market growth.
The digital genome is advanced progress in understanding animal and plant genetic material is being driven through advancements in DNA sequencing technology. It helps in gathering information related to chronic diseases and utilized to get an understanding of genetic disorders. A digital genome facilitates instant access to trait sequences to resolve unending custom queries.
A majority of older adults (>60%) suffer from two or more chronic conditions. Twin studies have long established that genes are the contributors to chronic conditions such as cardiovascular disease, diabetes, obesity, RA, Alzheimer's disease (AD), and depression. Recently, however, it has become possible to measure individual-level risks for these chronic diseases using molecular genetic data from genome-wide association studies (GWAS). Therefore, genetic sequencing makes them desirable for the screening of chronic diseases. According to World Health Organization (WHO), in 2005, almost 488,00 people died in UK due to chronic disease.
Cardiovascular diseases (CVDs) such as atherosclerosis, angina pectoris, and acute myocardial infarction are a significant cause of mortality owing to the present-day hectic lifestyle. Diabetes is one of the life-threatening chronic diseases with no functional cure. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with diabetes. As chronic diseases are increasing at a faster pace, the research on genomics for life-threatening illnesses has progressed rapidly over the last five years, thereby driving the market growth in the review period.
The outbreak of COVID-19 has led to thorough research on COVID-19 in the Europe. The European Commission and the European Bioinformatics Institute (EBI) have launched the European COVID-19 Data Portal. This brings together relevant datasets for sharing and analysis in an effort to accelerate COVID-19 research. Furthermore, ELIXIR provides a range of services that to the genomic researchers for studying the SARS-CoV-2 coronavirus and the COVID-19 disease. Thus, growing efforts for COVID19 research is expected to enhance the market growth of digital genome during the forecast period.
Rest of Europe Digital Genome Market,Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE DIGITAL GENOME MARKET SEGMENTATION
By Product
- Sequencing and Analyzer Instruments
- DNA/RNA Analysis
- Sequencing and Analysis Software
- Sequencing Chips
- Sample Prep Instruments
By Application
- Diagnostics
- Drug Discovery
- Academic Research
- Personalized Medicine
- Agricultural
- Other
By End-User
- Diagnostics and Forensic Labs
- Academic Research Institutes
- Hospitals
- Other
By Country
- Germany
- UK
- France
- Italy
- Spain
Company Profiles
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc
- F. HOFFMANN-LA ROCHE LTD
- QIAGEN
- bioMerieux SA
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Digital genome Market – By Product
1.3.2 Europe Digital genome Market – By Application
1.3.3 Europe Digital genome Market– By End User
1.3.4 Europe Digital genome Market – By Country
2. Europe Digital Genome Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Digital Genome Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Digital genome Market - Europe PEST Analysis
4.3 Expert Opinion
5. Europe Digital Genome Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Funding for Genomics
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Key Market Restraints
5.2.1 Security and Confidentiality Issue
5.3 Key Market Opportunities
5.3.1 Increasing Technological Advancement in Digital Genome Field
5.4 Future Trends
5.4.1 Increasing Demand for Personalized Medicines
5.5 Impact Analysis
6. Digital Genome Market – Europe Analysis
6.1 Europe Digital Genome Market Revenue Forecasts and Analysis
7. Europe Digital Genome Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 Europe Digital Genome Market, By Product 2019 & 2027 (%)
7.2.1 Europe Digital Genome Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 DNA/RNA Analysis
7.3.1 Overview
7.3.2 Europe DNA/RNA Analysis Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Sequencing and Analyzer Instruments
7.4.1 Overview
7.4.1.1 Europe Sequencing and Analyzer Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Sequencing and Analysis Software
7.5.1 Overview
7.5.2 Europe Sequencing and Analysis Software Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Sequencing Chips
7.6.1 Overview
7.6.2 Europe Sequencing Chips Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Sample Prep Instruments
7.7.1 Overview
7.7.2 Europe Sample Prep Instruments Market Revenue and Forecast to 2027 (US$ Mn)
8. Europe Digital Genome Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 Europe Digital Genome Market, By Application 2019 & 2027 (%)
8.2.1 Europe Digital genome Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Diagnostics
8.3.1 Overview
8.3.2 Europe Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Europe Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Academic Research
8.5.1 Overview
8.5.2 Europe Academic Research Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Personalized Medicine
8.6.1 Overview
8.6.2 Europe Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Agricultural
8.7.1 Overview
8.7.2 Europe Agricultural Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe Digital Genome Market Analysis – By End-User
9.1 Overview
9.2 Europe Digital Genome Market, By End-User 2019-2027 (%)
9.2.1 Europe Digital Genome Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Diagnostics and Forensic Labs
9.3.1 Overview
9.3.2 Europe Diagnostics and Forensic Labs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Academic Research Institutes
9.4.1 Overview
9.4.2 Europe Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Hospitals
9.5.1 Overview
9.5.2 Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Digital genome Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Europe Digital genome Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Europe: Digital Genome Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Europe: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.4 Europe: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.5 Europe: Digital Genome Market, by End User, 2018–2027 (USD Million)
10.1.6 Europe: Digital Genome Market, by Country, 2018 & 2027 (%)
10.1.7 Germany: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Germany: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Germany: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.7.3 Germany: Digital Genome Market, by Application, 2018–2027 (USD Million)
10.1.7.4 Germany: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.8 UK: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 UK: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 UK: Digital Genome Market, by Application, 2018–2027 (USD Million)
10.1.8.3 UK: Digital Genome Market, by End User, 2018–2027 (USD Million)
10.1.9 France: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 France: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 France: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.9.3 France: Digital Genome Market, by Application, 2018–2027 (USD Million)
10.1.9.4 France: Digital Genome Market, by End User, 2018–2027 (USD Million)
10.1.10 Spain: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Spain: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Spain: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.10.3 Spain: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.10.4 Spain: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.11 Italy: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Italy: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Italy: Digital Genome Market, by Product , 2018–2027 (USD Million)
10.1.11.3 Italy: Digital Genome Market, by Application, 2018–2027 (USD Million)
10.1.11.4 Italy: Digital Genome Market, by End User , 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Europe Digital Genome Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 QIAGEN
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 bioMerieux SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 THERMO FISHER SCIENTIFIC INC
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Illumina, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Digital Genome Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. Europe Digital genome Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. Europe Digital Genome Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 4. Europe Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. Europe Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 6. Europe Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 7. Germany Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. Germany Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 9. Germany Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 10. UK Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. UK Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 12. UK Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 13. France Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. France Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 15. France Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 16. Spain Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 17. Spain Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 18. Spain Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 19. Italy Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 20. Italy Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 21. Italy Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 22. Glossary of Terms, Digital Genome Market
LIST OF FIGURES
Figure 1. Digital Genome Market Segmentation
Figure 2. Europe Digital Genome Market Overview
Figure 3. The Sequencing and Analyzer Instruments Segment Held Largest Share of Digital Genome Market
Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Europe Digital Genome Market - Leading Country Markets (US$ Mn)
Figure 6. Digital genome Market - Europe PEST Analysis
Figure 7. Digital genome Market Impact Analysis of Driver and Restraints
Figure 8. Europe Digital Genome Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Europe Digital Genome Market, By Product 2019 & 2027 (%)
Figure 10. Europe DNA/RNA Analysis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Europe Sequencing and Analyzer Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Europe Sequencing and Analysis Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Europe Sequencing Chips Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Europe Sample Prep Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Europe Digital Genome Market, By Application 2019 & 2027 (%)
Figure 16. Europe Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Europe Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Europe Academic Research Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Europe Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Europe Agricultural Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Europe Digital Genome Market, by End-User 2019 & 2027 (%)
Figure 23. Europe Diagnostics and Forensic Labs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Europe Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Europe: Digital Genome Market, by Key Country – Revenue (2019) (USD Million)
Figure 28. Europe Digital Genome Market Revenue and Forecast to 2027 (USD Million)
Figure 29. Europe: Digital Genome Market, by Country, 2018 & 2027 (%)
Figure 30. Germany: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. UK: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. France: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Spain: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Italy: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Impact of COVID-19 Pandemic In European Country Markets
The List of Companies - Europe Digital Genome Market
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc
- F. HOFFMANN-LA ROCHE LTD
- QIAGEN
- bioMerieux SA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Digital Genome Market
Jul 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jul 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jul 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jul 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jul 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jul 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Jul 2020